• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Scanwell Health Launches Smartphone-Enabled At-Home Test & Treatment for UTIs, Raises $3.5M

by Jasmine Pennic 11/05/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Nationwide launch of Scanwell Health's at-home test & treatment service for UTIs

– Scanwell Health announces the nationwide launch of smartphone-enabled test and treatment service for urinary tract infections via partnership with Lemonaid Health.

– Company also announces $3.5 million in seed financing from investors including Founders Fund, Mayfield, DCM, Version One, Y Combinator, and Joe Montana’s Liquid 2 Ventures.

Scanwell Health, a Los Angeles, CA-based modern diagnostics company dedicated to making healthcare more convenient and accessible, announced that its at-home smartphone-enabled test and treatment service for Urinary Tract Infections (UTIs) is now available in all 50 states. Through a partnership with Lemonaid Health, a telehealth company that enables patients to quickly, safely and inexpensively receive care online, people across the country can now diagnose UTIs using Scanwell’s test and app, then receive immediate treatment from a Lemonaid physician or nurse practitioner.

Clinical-Grade and FDA-Cleared

Scanwell Health Launches Smartphone-Enabled At-Home Test & Treatment for UTIs, Raises $3.5M

Scanwell’s UTI test is the only FDA-cleared urine testing app available over-the-counter (OTC) without a prescription. The partnership with Lemonaid Health enables people across the country to diagnose UTIs using Scanwell’s test and app and receive immediate treatment from a Lemonaid physician or nurse practitioner.

Why Urinary Tract Infections?

About 50% of women will develop UTIs in their lifetime. Despite how common these infections are, less than half of US adults reported being able to get a same or next-day appointment with their primary care provider. Scanwell Health’s UTI test was conceived by founder, Stephen Chen, based on his experience developing Petnostics, an at-home urine testing solution to detect and monitor health conditions in dogs and cats. Petnostics was featured on Shark Tank and received a $300,000 offer from Lori Greiner and Kevin O’Leary.

Accessible, At-Home Testing

Using the Scanwell test kit and the Scanwell iOS or Android app, people can quickly and accurately determine whether they have a high concentration of leukocytes and nitrites in their urine, indicating that they could have a UTI. Scanwell’s test provides a result in as little as two minutes, with the same diagnostic accuracy as a urinalysis performed in a clinic. If the user has signs of a UTI they are directly connected with Lemonaid’s virtual team of physicians and nurse practitioners, who can prescribe antibiotics if needed. Scanwell’s tests are available via scanwellhealth.com for $15 per pack of three tests.

Partnership with Kaiser Permanente

Scanwell also has a partnership with Kaiser Permanente and the Chronic Renal Insufficiency Cohort (CRIC) Study to improve screening for and monitoring chronic kidney disease (CKD) at home. Through this collaboration, Scanwell is using its urinalysis technology to screen participants’ urine for excess proteins. Increased access to screening may help identify CKD in more people at an earlier stage, allowing for timely lifestyle interventions to help stem the progression of the disease.

Seed Funding

In addition, the company also announced that it has raised $3.5M of seed funding from investors including Founders Fund, Mayfield, DCM, Version One, Y Combinator and Joe Montana’s Liquid 2 Ventures. The proceeds of the financing will be used to support the national launch, develop new diagnostics and hire additional team members.

 “This funding from an incredible group of investors, together with the national launch of our test and app, are exciting milestones that will allow us to realize our vision of making reliable, convenient at-home testing available to millions of people,” said Stephen Chen, founder and CEO of Scanwell Health. “Our partnership with Lemonaid is only the beginning. We have a number of additional diagnostic tests in the pipeline that have the potential to change the way we diagnose and treat infections and monitor chronic diseases. We look forward to working with additional partners to bring these tests to people across the country.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: FDA, Kaiser Permanente, Kidney Disease, Lemonaid Health, Partners, physicians, Primary Care, Scanwell Health, Y Combinator

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |